Wenxin Wu
- Topics
- Nanoplatforms for cancer theranostics (3 papers)Anesthesia and Pain Management (2 papers)Immunotherapy and Immune Responses (2 papers)
- Cited by
- ImmunologyOncologyCancer Research
In The Last Decade
Wenxin Wu
20 papers receiving 307 citations
Peers
Comparison fields: 5 of 70
- Oncology 139
- Immunology 116
- Molecular Biology 90
- Biomedical Engineering 56
- Cancer Research 34
Countries citing papers authored by Wenxin Wu
This map shows the geographic impact of Wenxin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxin Wu more than expected).
Fields of papers citing papers by Wenxin Wu
This network shows the impact of papers produced by Wenxin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxin Wu. The network helps show where Wenxin Wu may publish in the future.
Co-authorship network of co-authors of Wenxin Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Wenxin Wu. A scholar is included among the top collaborators of Wenxin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxin Wu. Wenxin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 11 | |
| 7 | 7 | |
| 8 | 6 | |
| 9 | 4 | |
| 10 | 0 | |
| 11 | 6 | |
| 12 | 25 | |
| 13 | 27 | |
| 14 | 15 | |
| 15 | Clinical significance of AJUBA, YAP1, and MMP14 expression in esophageal squamous cell carcinoma. | 8 |
| 16 | 13 | |
| 17 | Low expression of KLF17 is associated with tumor invasion in esophageal carcinoma. | 12 |
| 18 | 2 | |
| 19 | 19 | |
| 20 | 135 |
About Wenxin Wu
Wenxin Wu is a scholar working on Cancer Research, Hepatology and Developmental Neuroscience, having authored 24 papers that have together received 311 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (3 papers), Anesthesia and Pain Management (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Immunology (116 citations), Oncology (139 citations) and Cancer Research (34 citations). Wenxin Wu has collaborated with scholars based in China and Indonesia. Frequent co-authors include Bin Shi, Xiaohua Wu, Chunyang Zhang, Tan Yang, Tongyi Huang, Xintao Shuai, Ming Xu, Yuehong Li, Bin Qiao and Luyao Zhou. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biomaterials and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.